Clinical Trials Logo

Filter by:
NCT ID: NCT06087224 Recruiting - Morbidity;Newborn Clinical Trials

The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals

Start date: March 5, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the impact of real-time audio-video telemedicine consults with a neonatologist (termed teleneonatology) on the early health outcomes of at-risk neonates delivered in community hospitals.

NCT ID: NCT06087198 Recruiting - Thrombocytopenia Clinical Trials

Clinical Performance Evaluation of T-TAS®01 HD Chip

Start date: September 25, 2023
Phase:
Study type: Observational

The study is being conducted to validate the clinical performance of the T-TAS 01 HD assay for measurement of thrombogenicity in patients with thrombocytopenia receiving a platelet transfusion.

NCT ID: NCT06087133 Recruiting - Pregnancy Clinical Trials

Prenatal Starting Early Program mHealth

Start date: December 8, 2023
Phase: N/A
Study type: Interventional

The purpose of this interventional trial is to test the efficacy of the remote delivery of the StEP:Prenatal intervention compared to standard prenatal care in pregnant individuals planning to receive prenatal and pediatric care at Bellevue Hospital. The primary aims are to determine the efficacy of the remotely delivered StEP:Prenatal intervention on diet, lifestyle behaviors, social determinants of health (SDoH), and pregnancy outcomes.

NCT ID: NCT06087029 Recruiting - Clinical trials for Type B Aortic Dissection

IMPRoving Outcomes in Vascular DisEase- Aortic Dissection

IMPROVE-AD
Start date: April 14, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to determine whether an upfront invasive strategy of TEVAR plus medical therapy reduces the occurrence of a composite endpoint of all-cause death or major aortic complications compared to an upfront conservative strategy of medical therapy with surveillance for deterioration in patients with uncomplicated type B aortic dissection.

NCT ID: NCT06086795 Recruiting - Clinical trials for Inflammatory Response

Investigating Age-dependent Effects of Egg Intake on HDL and Immune Profiles

Start date: January 23, 2024
Phase: N/A
Study type: Interventional

The goal of this intervention study is to determine whether consumption of different fractions of chicken eggs, including egg whites, egg yolks, and whole eggs, confer different changes in markers of HDL function and T cell profiles in younger vs. older men and women. The study will address the following objectives: - Objective 1: Determine if daily consumption of egg fractions differentially alter HDL profiles across age groups. - Objective 2: Determine if daily consumption of egg fractions differentially alter immune cell profiles across age groups. Participants will be asked to consume egg whites, egg yolks, and whole eggs on a daily basis for 4-weeks each, and avoid eating eggs for a total of 8 weeks at different points in the study. Participants will additionally be provided guidance on following a generally healthy diet, and will be asked to complete surveys about dietary intake and physical activity, as well as provide blood samples throughout the course of the study. Researchers will compare whether daily consumption of egg whites, egg yolks, and whole eggs differentially alter markers of HDL function and T cell profiles in younger vs. older adults.

NCT ID: NCT06086756 Completed - Public Speaking Clinical Trials

Virtual Reality Intervention for Speech Anxiety

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present study is designed to evaluate whether mood state moderates outcome to a brief VR exposure intervention.

NCT ID: NCT06086704 Recruiting - Breast Cancer Clinical Trials

Study of 18F-FFNP Breast PET/MRI

Start date: June 2024
Phase: Phase 2
Study type: Interventional

This clinical trial will investigate an estrogen-regulated parameter as an early measure of endocrine therapy response: progesterone receptor (PR) protein with a progestin-based radioligand, 18F-fluorofuranylnorprogesterone (18F-FFNP). The overall purpose of this research is to test the efficacy of 18F-FFNP PET/MRI for predicting response to presurgical endocrine therapy and to determine the quantitative reliability of 18F-FFNP breast PET/MRI in patients with newly diagnosed ER+/PR+/HER2- primary breast cancer.

NCT ID: NCT06086626 Recruiting - Clinical trials for Gram-Negative Bacterial Infections

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

Start date: March 14, 2024
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to understand the pharmacokinetics (PK) of single and multiple doses of cefiderocol in children from birth to less than 3 months of age with suspected or confirmed aerobic Gram-negative bacterial infections.

NCT ID: NCT06086613 Recruiting - Clinical trials for Osteogenesis Imperfecta

A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers

Start date: October 3, 2023
Phase: Phase 1
Study type: Interventional

To understand if AGA2115 is safe and well tolerated in healthy adult volunteers.

NCT ID: NCT06086561 Recruiting - Hydrocephalus Clinical Trials

Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device

Start date: November 17, 2023
Phase: N/A
Study type: Interventional

This study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow. Patients with an existing implanted shunt will wear the device to acquire longitudinal data.